Treatment of coronary or peripheral ischemia

Details for Australian Patent Application No. 2004309090 (hide)

Owner Centelion Aventis Pharma SA

Inventors Caron, Alexis; Uzan, Andre

Agent MIDDLETONS LAWYERS

Pub. Number AU-A-2004309090

PCT Pub. Number WO2005/063807

Priority 60/532,993 29.12.03 US

Filing date 29 December 2004

Wipo publication date 14 July 2005

International Classifications

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

A61K 31/727 (2006.01)

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/063807 Priority application(s): WO2005/063807

26 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004309111-CC-chemokine-binding tick proteins

2004309089-Synthetic compounds useful as nodulation agents of leguminous plants and preparation processes thereof